[go: up one dir, main page]

DK0451082T3 - Ophthalmisk produkt - Google Patents

Ophthalmisk produkt

Info

Publication number
DK0451082T3
DK0451082T3 DK91500033.5T DK91500033T DK0451082T3 DK 0451082 T3 DK0451082 T3 DK 0451082T3 DK 91500033 T DK91500033 T DK 91500033T DK 0451082 T3 DK0451082 T3 DK 0451082T3
Authority
DK
Denmark
Prior art keywords
nanocapsules
ophthalmic product
ophthalmic
application
relates
Prior art date
Application number
DK91500033.5T
Other languages
English (en)
Inventor
Philippe Maincent
Daniel Sirdat
Laurent Marchal-Heussler
Original Assignee
Cusi Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cusi Lab filed Critical Cusi Lab
Application granted granted Critical
Publication of DK0451082T3 publication Critical patent/DK0451082T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Electroluminescent Light Sources (AREA)
DK91500033.5T 1990-04-03 1991-04-02 Ophthalmisk produkt DK0451082T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004491A FR2660193B1 (fr) 1990-04-03 1990-04-03 Produit opthalmique comportant des nanocapsules, son procede de preparation et utilisation des nanocapsules.

Publications (1)

Publication Number Publication Date
DK0451082T3 true DK0451082T3 (da) 1995-06-19

Family

ID=9395546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91500033.5T DK0451082T3 (da) 1990-04-03 1991-04-02 Ophthalmisk produkt

Country Status (9)

Country Link
US (1) US5308624A (da)
EP (1) EP0451082B1 (da)
JP (1) JPH0723325B2 (da)
AT (1) ATE116846T1 (da)
DE (1) DE69106560T2 (da)
DK (1) DK0451082T3 (da)
ES (1) ES2071275T3 (da)
FR (1) FR2660193B1 (da)
GR (1) GR3015693T3 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
FR2692167B1 (fr) * 1992-06-16 1994-09-16 Centre Nat Rech Scient Préparation et application de nouveaux systèmes colloïdaux nanovésiculaires dispersibles à base de cyclodextrine, sous forme de nanocapsules.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5877224A (en) * 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
FR2766368B1 (fr) * 1997-07-24 2000-03-31 Univ Claude Bernard Lyon Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
DE19756314C2 (de) * 1997-12-12 2000-06-29 Roland Bodmeier Zubereitung mit verlängerter Verweildauer am Applikationsort
EP1043983A4 (en) * 1997-12-30 2005-03-30 Bioabsorbable Concepts Inc TETRACYCLINE AND / OR ONE OR MORE DERIVATIVES OF TETRACYCLINE FOR TREATING, DELETING OR PREVENTING CEREBROVASCULAR DISEASES OF THE NERVOUS SYSTEM
PT1676579E (pt) * 1998-05-08 2009-03-24 Univ Miami Utilização de tetraciclinas sub-antimicrobianas para o tratamento de rosácea ocular
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
KR100777195B1 (ko) * 2000-04-03 2007-11-19 산텐 세이야꾸 가부시키가이샤 송달성 물질 및 이를 이용한 약물 송달 시스템
AU2001280165A1 (en) * 2000-08-24 2002-03-04 Santen Pharmaceutical Co. Ltd. Drug-release controlling system
WO2003005971A2 (en) 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
CN1318093C (zh) * 2001-09-28 2007-05-30 参天制药株式会社 含与聚乙二醇结合的药物的眼组织注射剂
US20060057216A1 (en) * 2004-09-15 2006-03-16 Salamone Joseph C Low-obscuration image transmitting particulate ocular therapeutic formulations
JP2006257080A (ja) * 2005-02-18 2006-09-28 Santen Pharmaceut Co Ltd ステロイド化合物の副作用軽減または回避方法
CN109646422A (zh) * 2019-01-18 2019-04-19 广东药科大学 一种聚丙烯酸树脂包裹载药蒙脱石的眼部给药系统的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795436A (en) * 1983-11-14 1989-01-03 Bio-Mimetics, Inc. Bioadhesive composition and method of treatment therewith
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
DE3722837A1 (de) * 1987-07-10 1989-01-19 Ruetgerswerke Ag Ophthalmisches depotpraeparat
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants

Also Published As

Publication number Publication date
FR2660193B1 (fr) 1994-11-04
GR3015693T3 (en) 1995-07-31
JPH0723325B2 (ja) 1995-03-15
ES2071275T3 (es) 1995-06-16
EP0451082A1 (en) 1991-10-09
DE69106560D1 (de) 1995-02-23
DE69106560T2 (de) 1995-05-11
ATE116846T1 (de) 1995-01-15
JPH04221322A (ja) 1992-08-11
US5308624A (en) 1994-05-03
EP0451082B1 (en) 1995-01-11
FR2660193A1 (fr) 1991-10-04

Similar Documents

Publication Publication Date Title
DK0451082T3 (da) Ophthalmisk produkt
FI99086C (fi) Ultraäänivarjoaineita, menetelmä niiden valmistamiseksi ja niiden käyttö diagnostisina aineina
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE59003791D1 (de) Verfahren zur Herstellung von 1,3,3-Trimethyl-5-oxo-cyclohexan-carbonitril.
DE69101984D1 (de) Verfahren zur Herstellung von gesäuertem Milchprodukt.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
NO304949B1 (no) Nye glukose- og soforoselipider, en fremgangsmÕte for fremstilling derav og anvendelse av lipidene
PT90311A (pt) Processo para a obtencao de proteinas antigenicas imunoprotectoras contra bacterias patogenicas
DE69013132D1 (de) Verfahren zur Herstellung von Octa-2,7-dien-1-ol.
DE69007965D1 (de) Apparatur zur herstellung von alpha-beta-ungesättigten nitrilen.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
DE69004170D1 (de) Verfahren zur Herstellung eines pflanzlichen Eiweisshydrolysats und so hergestelltes Produkt.
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
DE59003230D1 (de) Verfahren zur Herstellung von 2,4- bzw. 2,6-Dihalogen-anilin.
PT82536A (de) Verfahren zur herstellung von 17alpha-ethinyl-17 beta-hydroxy-18-methyl-4,15-estradien-3-on und die neuen ausgangsverbindungenfur dieses verfahren
DE58907891D1 (de) Verfahren zur Sterilisation von intraocularen Linsen.
DE69625562D1 (de) Verfahren zur Herstellung von optisch aktiven Cyclohexanolderivaten
DE59006265D1 (de) Verfahren zur Herstellung von 2-Amino-4-fluorpyrimidinderivaten.
DE69018028D1 (de) Verfahren zur Herstellung von 2-substituierten-1,4-Naphtochinonen.
DE69019543D1 (de) Verfahren zur Herstellung biologisch aktiver Polysaccharid-RON-Substanz.
DE69012857D1 (de) Verfahren zur Herstellung von para-Hydroxybenzylalkohol.